4.3 Article

Cohort profile: Evaluation of the Methods a nd Management of Acute Coronary Events (EMMACE) Longitudinal Cohort

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ehjqcco/qcad040

Keywords

Myocardial infarction; Outcomes; Hospitalizations; Medications; Health-related quality of life; Cohort; Electronic health records; Longitudinal data

Ask authors/readers for more resources

The EMMACE longitudinal cohort study aims to investigate the health trajectories of patients following myocardial infarction hospitalization. The study collected data from 14,899 MI patients admitted to 77 hospitals in England and conducted long-term follow-up. It focuses on patient outcomes, medication adherence, and health-related quality of life.
Aims The Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort study aims to investigate health trajectories of individuals following hospitalization for myocardial infarction (MI)............................................................................................................................................................................................. Methods and results EMMACE is a linked multicentre prospective cohort study of 14 899 patients with MI admitted to 77 hospitals in England who participated in the EMMACE-3 and -4 studies between 1st November 2011 and 24th June 2015. Long-term followup of the EMMACE cohorts was conducted through the EMMACE-XL (27th September 2020 to 31st March 2022) and EMMACE-XXL (1st July 2021 to 1st July 2023) studies. EMMACE collected individual participant data for health-related quality of life (HRQoL) measured by three-level EuroQol five-dimension and visual analogy scale at admission, 1 month, 6 months, 12 months, and 10 years follow-up, as well as medications, medication adherence, beliefs about medicines, Satisfaction with Information about Medicines Scale, and illness perceptions. Participant data were deterministically linked to the Myocardial Infarction National Audit Project (MINAP) for information on baseline treatments and comorbidities, Hospital Episode St atistics Admitted Patient Care (for cause-specific hospitalization data), and the Office for National Statistics (for mortality data) up to 2020............................................................................................................................................................................................. Conclusion EMMACE is a nationwide prospective cohort that will provide unique insights into fatal and non-fatal outcomes, medication adherence, and HRQoL following MI. Trial registration: ClinicalTrials.gov NCT01808027 and NCT01819103

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available